Ozempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads

Sources

Coverage

Limited spectrum

Sentiment

+0.10

◀ Left 100%Centre 0%Right 0% ▶

How we rate bias →

This story is currently only covered by one source from a single part of the political spectrum. NewsDeck will update this page automatically if other outlets pick up the story.

shopping_bagAmazon Kindle

A dedicated e-reader for the books above — easier on the eyes than a phone screen.

Browse Kindles on Amazonarrow_forward

NewsDeck Poll

Do you think this story is being covered fairly across the political spectrum?

Loading…

Left

(1)

Guardian Business

Neutral

Ozempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads

Danish pharma company says Eli Lilly using outdated trial data to make its weight-loss drugs appear more effective Ozempic maker Novo Nordisk said on Tuesday it is suing arch US rival Eli Lilly over “false and materially misleading” adverts for its competing weight-loss and anti-diabetes treatments. The Danish pharmaceuticals heavyweight complained that the US group – which makes rival weight-loss treatments Zepbound…